Closer to FDA approval in USA for Cannabis Children Epilepsy drug

I find this interesting and great news for MGC Shareholders. GW Pharma received unanimous vote to approve an Epilepsy drug in the USA.  From the article looks like 6/27, it goes to FDA.

Share prices of GW have been soaring (high of $140 US- market cap of $3.9 billion).  By 6/27 Cannepil should be available in Australia/ Europe- if the FDA approves the drug for children, it opens the door in the US for Cannepil, especially considering Cannepil should be on market by then.   

GW Pharma Gets Unanimous Support for Epidiolex Approval from FDA Advisory Committee
https://www.newcannabisventures.com...idiolex-approval-from-fda-advisory-committee/